Biofarm Finland News and Activities

Biofarm Finland is owned by Polpharma. Polpharma has a direct presence in 3 countries.

Acquisition, funding and merger involving Polpharma.

• Polpharma has acquired Biofarm (posted on June 24 2026).

View the org chart displaying its 5 main executives

Most searched biographies at Biofarm Finland

• Mikko Koivu, Chief Executive Officer
• Tiina Kauhanen, Head of Production and Quality
• Mika Brofeldt, Marketing Manager

Popular executive movements at Polpharma

• Markus Sieger, Chief Executive Officer, will leave the company on Jan. 1, 2026  (posted on October 29 2025).
• Sebastian Szymanek who is President, Usine pharmaceutique Polpharma, will become Chief Executive Officer on Jan. 1, 2026  (posted on October 28 2025).

Create your alert
to follow the executive moves at Biofarm Finland.

Polpharma has 1,919 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Catalyst Pharmaceuticals, listed under ticker CPRX, has been delisted. (posted on July 13 2026).
• Angelini Pharma has acquired Catalyst Pharmaceuticals (posted on July 13 2026).
• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Biofarm Finland

Social media about Biofarm Finland

• Biofarm Finland on Wikipedia, Google News & Yahoo Finance
• Biofarm Finland on LinkedIn, X (Twitter) & YouTube